Get the Stockscreener App
3.82
0.65%
-0.025
After Hours:
3.77
-0.05
-1.31%
Evoke Pharma Inc Stock (EVOK) Forecast
The Evoke Pharma Inc (EVOK) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.0037, representing a +83.34% increase from the current price of $3.82. The highest analyst price target is $10.88, and the lowest is $3.1278.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVOK Price Target
Average 35.05
(+817.63% Upside)
Is Evoke Pharma Inc (EVOK) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.03 | Neutral |
| STOCH(9,6) | 26.12 | Neutral |
| STOCHRSI(14) | 43.93 | Neutral |
| MACD(12,26) | -0.2851 | Sell |
| ADX(14) | 28.83 | Sell |
| William %R | -75.64 | Neutral |
| CCI(14) | -48.01 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.8269
Sell
|
3.9573
Sell
|
| MA20 |
4.4266
Sell
|
4.2137
Sell
|
| MA50 |
4.5325
Sell
|
4.4828
Sell
|
| MA100 |
4.7352
Sell
|
4.7182
Sell
|
| MA200 |
5.1083
Sell
|
5.5985
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EVOK could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on EVOK, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.03 indicates that EVOK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.12 indicates that EVOK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.93 indicates that EVOK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.83 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -48.01 indicates that EVOK is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EVOK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evoke Pharma Inc financial reports and earnings history, Evoke Pharma Inc (EVOK) stock could reach $7.6485 by 2030, $3.9904 by 2040 and $11.19 by 2050. See the projected annual prices until 2050 of the Evoke Pharma Inc stock below:
- Evoke Pharma Inc (EVOK) is expected to reach an average price of $1.0013 in 2035, with a high prediction of $1.224 and a low estimate of $1.0713. This indicates an $-73.79% rise from the last recorded price of $3.82.
- Evoke Pharma Inc (EVOK) stock is projected to chart a bullish course in 2040, with an average price target of $3.9574, representing an $3.60% surge from its current level. The forecast ranges from a conservative $3.9636 to a sky-high $3.9904.
- Our analysts predict Evoke Pharma Inc (EVOK) to jump 136.06% by 2045, soaring from $9.0565 to an average price of $9.0175, potentially reaching $8.814. While $9.0565 is the low estimate, the potential upside is significant.
- Evoke Pharma Inc (EVOK) stock is expected to climb by 2050, reaching an average of $11.19, a $192.96% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.19 and $10.73, respectively, highlighting the market's uncertainty.
Evoke Pharma Inc Stock (EVOK) Year by Year Forecast
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2025
Evoke Pharma Inc Stock (EVOK) is expected to reach an average price of $35.05 in 2025, with a high prediction of $66.98 and a low estimate of $3.1278. This indicates an +817.63% rise from the last recorded price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $7.676 | $3.1278 | $10.88 | +100.94% |
| May, 2025 | $9.6311 | $5.72 | $11.31 | +152.12% |
| June, 2025 | $11.53 | $8.2164 | $11.89 | +201.80% |
| July, 2025 | $22.21 | $11.91 | $27.61 | +481.39% |
| August, 2025 | $35.75 | $32.67 | $54.03 | +835.74% |
| September, 2025 | $44.48 | $33.85 | $47.46 | +1,064% |
| October, 2025 | $60.08 | $43.43 | $66.98 | +1,473% |
| November, 2025 | $50.70 | $47.19 | $61.31 | +1,227% |
| December, 2025 | $40.38 | $39.66 | $54.49 | +957.04% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2026
The predicted value for Evoke Pharma Inc (EVOK) in 2026 is set at an average of $29.83. Estimates vary from a peak of $52.52 to a trough of $7.1428, indicating an +680.98% surge from the present price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $31.12 | $28.90 | $41.36 | +714.54% |
| February, 2026 | $29.65 | $26.89 | $33.92 | +676.22% |
| March, 2026 | $28.19 | $24.78 | $38.99 | +637.91% |
| April, 2026 | $35.99 | $25.00 | $52.52 | +842.11% |
| May, 2026 | $22.28 | $21.29 | $37.17 | +483.37% |
| June, 2026 | $18.06 | $15.85 | $22.85 | +372.80% |
| July, 2026 | $8.9415 | $8.7015 | $18.09 | +134.07% |
| August, 2026 | $12.52 | $8.3897 | $13.12 | +227.69% |
| September, 2026 | $10.48 | $9.0383 | $13.38 | +174.30% |
| October, 2026 | $8.4146 | $8.0102 | $11.01 | +120.28% |
| November, 2026 | $9.711 | $7.1428 | $14.56 | +154.21% |
| December, 2026 | $11.39 | $8.4392 | $12.59 | +198.20% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evoke Pharma Inc (EVOK) is $35.64, with a high forecast of $71.25 and a low forecast of $0.0266. This indicates an +832.95% increase from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.01 | $9.6396 | $13.26 | +188.16% |
| February, 2027 | $6.6029 | $6.1841 | $12.28 | +72.85% |
| March, 2027 | $3.2529 | $2.1764 | $6.8202 | -14.85% |
| April, 2027 | $2.3041 | $2.178 | $3.9274 | -39.68% |
| May, 2027 | $2.2984 | $1.889 | $3.4731 | -39.83% |
| June, 2027 | $3.608 | $2.5373 | $4.6254 | -5.55% |
| July, 2027 | $2.454 | $1.9498 | $3.8217 | -35.76% |
| August, 2027 | $1.5363 | $0.9086 | $2.5489 | -59.78% |
| September, 2027 | $0.3893 | $0.2813 | $71.25 | -89.81% |
| October, 2027 | $0.0571 | $0.6552 | $0.567 | -98.51% |
| November, 2027 | $0.2134 | $0.0266 | $0.3653 | -94.41% |
| December, 2027 | $0.1861 | $0.0343 | $0.7398 | -95.13% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2028
In 2028, Evoke Pharma Inc (EVOK) is projected to reach an average price of $1.8594, with a high projection of $3.6783 and a low estimate of $0.0405. This indicates an -51.33% fall from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2898 | $0.3039 | $0.1598 | -92.41% |
| February, 2028 | $0.8935 | $0.4957 | $0.4635 | -76.61% |
| March, 2028 | $0.913 | $0.8453 | $0.853 | -76.10% |
| April, 2028 | $1.0467 | $0.9908 | $0.9567 | -72.60% |
| May, 2028 | $0.1937 | $0.5364 | $0.9726 | -94.93% |
| June, 2028 | $1.6401 | $0.2519 | $1.664 | -57.07% |
| July, 2028 | $0.9364 | $0.7164 | $3.6783 | -75.49% |
| August, 2028 | $1.4869 | $0.5405 | $1.5869 | -61.08% |
| September, 2028 | $0.00319 | $0.185 | $1.6059 | -99.92% |
| October, 2028 | $0.2995 | $0.0405 | $0.4794 | -92.16% |
| November, 2028 | $0.145 | $0.0586 | $0.5035 | -96.20% |
| December, 2028 | $0.0537 | $0.1837 | $0.2081 | -98.59% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2029
The 2029 price forecast for Evoke Pharma Inc Stock (EVOK) is $3.0967 on average, with a high prediction of $6.186 and a low estimate of $0.00735. This represents an -18.94% decrease from the previous price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0367 | $0.00735 | $0.1426 | -99.04% |
| February, 2029 | $0.4069 | $0.0292 | $0.217 | -89.35% |
| March, 2029 | $0.2306 | $0.2188 | $0.1947 | -93.96% |
| April, 2029 | $0.0241 | $0.0483 | $0.2076 | -99.37% |
| May, 2029 | $0.0762 | $0.0556 | $0.1562 | -98.01% |
| June, 2029 | $0.3025 | $0.0303 | $0.3403 | -92.08% |
| July, 2029 | $0.0692 | $0.0461 | $0.3966 | -98.19% |
| August, 2029 | $0.1807 | $0.043 | $0.193 | -95.27% |
| September, 2029 | $0.1233 | $0.1444 | $0.1166 | -96.77% |
| October, 2029 | $0.0419 | $0.063 | $0.092 | -98.90% |
| November, 2029 | $0.0791 | $0.0353 | $0.0792 | -97.93% |
| December, 2029 | $7.0524 | $0.0351 | $6.186 | +84.62% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2030
Evoke Pharma Inc Stock (EVOK) is expected to reach an average price of $4.3711 in 2030, with a high forecast of $8.3902 and a low forecast of $0.3519. This signifies an +14.43% surge from the last price of $3.82.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.2639 | $7.1921 | $7.6485 | +90.16% |
| February, 2030 | $3.8997 | $6.3513 | $6.7622 | +2.09% |
| March, 2030 | $3.6182 | $3.6374 | $2.5586 | -5.28% |
| April, 2030 | $2.3659 | $3.6847 | $3.0742 | -38.07% |
| May, 2030 | $3.265 | $2.7965 | $3.0838 | -14.53% |
| June, 2030 | $3.5176 | $4.0924 | $3.4687 | -7.92% |
| July, 2030 | $3.2285 | $0.3715 | $6.4685 | -15.48% |
| August, 2030 | $4.8612 | $2.8212 | $7.2848 | +27.26% |
| September, 2030 | $4.6627 | $3.4951 | $6.7094 | +22.06% |
| October, 2030 | $4.9347 | $3.2066 | $8.3902 | +29.18% |
| November, 2030 | $1.3742 | $0.4889 | $6.3029 | -64.03% |
| December, 2030 | $0.0799 | $0.3519 | $2.153 | -97.91% |
1.26%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):